Infectious Disease Diagnostics Market 2024-2028: Size and Availability of counterfeit drugs in developing economics; growth driven by the End-user, Some of key Companies Positioned Strategically

The infectious disease diagnostics market size by End-user (Hospitals and Labs) and Geography (North America, Europe, Asia, and Rest of World (ROW)), is forecast to increase by USD 8.90 billion. The market is expected to grow at a CAGR of   4.5% between 2024 and 2028.

• The global infectious disease diagnostics market faces a significant challenge with the proliferation of counterfeit products. Counterfeiting in the pharmaceutical industry is a persistent issue, leading to the introduction of duplicate goods into the marketplace. The financial implications for manufacturers are substantial, with losses amounting to billions of dollars, not to mention the negative impact on brand reputation. Patients are unwittingly put at risk as these counterfeit drugs offer a false sense of security while potentially exposing them to even greater harm. The prevalence of counterfeit drugs is particularly acute in low-income and developing countries, where regulatory oversight and manufacturing controls are insufficient. This situation not only undermines the efficacy of infectious disease diagnostics but also poses a threat to public health.
• The Infectious Disease Diagnostics Market represents a significant business opportunity due to the ongoing global health crisis and the increasing demand for accurate and rapid diagnostic solutions. This market is driven by factors such as the rising prevalence of infectious diseases, growing government funding for research and development, and advancements in diagnostic technologies. Companies in this sector are focusing on innovations that enhance the speed, sensitivity, and specificity of diagnostic tests, enabling early detection and effective treatment. The market is expected to grow robustly in the coming years, offering substantial returns for investors.

Access the full report to know who are the other key countries segment-wise forecast and historic data

Some of the Key Companies:

• Abbott Laboratories
• Becton Dickinson and Co.
• Bio Rad Laboratories Inc.
• bioMerieux SA
• Danaher Corp.
• DiaSorin Spa
• F. Hoffmann La Roche Ltd.
• Genetic Signatures Ltd.
• Grifols SA
• Hologic Inc.
• Meridian Bioscience Inc.
• Meril Life Sciences Pvt. Ltd.
• OraSure Technologies Inc.
• Perkin Elmer Inc.
• QIAGEN NV
• Siemens AG
• Sysmex Corp.
• Thermo Fisher Scientific Inc.
• Trinity Biotech Plc
• Vela Diagnostics

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/